114th Day Of Lockdown

Maharashtra27564015261310928 Tamil Nadu1518201023102167 Delhi116993956993487 Karnataka4725318467933 Gujarat44648313462080 Uttar Pradesh41383257431012 Telangana3934225999386 Andhra Pradesh3545118378452 West Bengal34427206801000 Rajasthan2643719502530 Haryana2330617667319 Bihar2017313533157 Assam197551288953 Madhya Pradesh1964313908682 Odisha1489810476101 Jammu and Kashmir116666337206 Kerala9554463436 Punjab87995867221 Jharkhand4562248538 Chhatisgarh4556332420 Uttarakhand3785294850 Goa2951167418 Tripura228116043 Manipur170010800 Puducherry159688921 Himachal Pradesh134196610 Nagaland9023480 Chandigarh61945911 Arunachal Pradesh4911533 Meghalaya337462 Mizoram2381590 Sikkim222870
World Europe 27 May 2020 France bans hydroxyc ...

France bans hydroxychloroquine for coronavirus treatment

AFP
Published May 27, 2020, 3:42 pm IST
Updated May 27, 2020, 3:42 pm IST
Under the new French rules, the drug can be used only in clinical trials to test its efficacy against coronavirus
A pharmacy tech holds a bottle and a pill of Hydroxychloroquine. (AFP)
 A pharmacy tech holds a bottle and a pill of Hydroxychloroquine. (AFP)

Paris: The French government on Wednesday banned treatment of COVID-19 patients with hydroxychloroquine, a controversial and potentially harmful drug that US President Donald Trump has said he is taking preventively.

The move came after two French advisory bodies and the World Health Organization warned this week that the drug -- a treatment for rheumatoid arthritis and lupus -- had been shown to be potentially dangerous in several studies.

 

The urgency of the coronavirus outbreak has prompted some doctors to prescribe the drug despite a lack of research to demonstrate its efficacy against the novel coronavirus.

Among them were a French infectious disease specialist who caught the ear of Trump, who stunned his own administration last week by revealing he was taking hydroxychloroquine as a preventive measure against COVID-19.

Under the new French rules, the drug can be used only in clinical trials to test its efficacy against coronavirus -- making it unclear if the French doctor, Didier Raoult, would be able to continue using it at his hospital in Marseille in the south.

 

Raoult has already rejected a comprehensive study published last week in The Lancet medical journal, which found that administering hydroxychloroquine or its related compound chloroquine actually increased the risk of dying for many patients.

Hydroxychloroquine also used to treat malaria, is sold under the brand name Plaquenil by French pharma giant Sanofi, which promised to offer governments millions of doses if studies proved it could be safely used in the coronavirus fight.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT